Genex Pharma Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: Genex Pharma Pharmaceutical Export Portfolio Dataset — 8 Products, $374.1K FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Genex Pharma — Pharmaceutical Exporter Profile (2026) | 8 Products, $374.1K Trade | TransData Nexus

Product Portfolio — Top 8 by Export Value

Genex Pharma exports 8 pharmaceutical products across 6 therapeutic categories.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Protein	Nutritional Supplements	$108.7K	12	0.7%	12
2	Nitroglycerin	Cardiovascular	$106.3K	20	1.1%	12
3	Indomethacin	Analgesics & Antipyretics	$51.5K	11	0.5%	15
4	Temozolomide	Advanced Oncology	$34.7K	11	0.1%	12
5	Digoxin	Cardiovascular	$28.1K	25	1.3%	12
6	Teicoplanin	Advanced Antibiotics	$24.0K	10	0.4%	10
7	Mercaptopurine	Advanced Oncology	$13.1K	16	2.2%	8
8	Adalimumab	Biologics & Immunotherapy	$7.7K	3	0.6%	9

Genex Pharma exports 8 pharmaceutical products across 6 therapeutic categories with a total export value of $374.1K. The top category is Cardiovascular (35.9% of portfolio), followed by Nutritional Supplements (29.1%), indicating a concentrated portfolio with the top 5 products accounting for 88.0% of total export value.

Genex Pharma — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

Genex Pharma, established in 2007, is a reputable Indian pharmaceutical company specializing in the manufacturing and export of life-saving medicines. Headquartered in Goregaon (W), Mumbai, Maharashtra, the company operates with a strong presence in over 50 countries worldwide. Genex Pharma is committed to ethical operations and integrity across its global activities.

The company is privately held and operates as a partnership. As of the latest available data, Genex Pharma employs between 11 to 50 individuals. The Corporate Identification Number (CIN) is not publicly disclosed. While specific revenue figures are not publicly available, the company has demonstrated consistent growth and expansion in its export activities.

2Manufacturing Facilities

Genex Pharma operates WHO-GMP compliant manufacturing facilities, ensuring adherence to international quality standards. The company has a strong presence in over 50 countries worldwide, reflecting its commitment to global healthcare.

3Key Leadership

The leadership team at Genex Pharma comprises individuals with extensive experience in the pharmaceutical industry. Mr. Chirag Shah, with over two decades in the sector, serves as a key figure in the company's operations. Mr. Rajiv Shah brings 35 years of expertise, particularly in manufacturing and product development. Mr. Pranav Shah, with nearly four decades in marketing and administration, emphasizes ethical practices and regulatory compliance.

TransData Nexus Research · Government registries, company filings, regulatory databasesMar 2026

Where Does Genex Pharma Export? — Destination Intelligence

Regulated market presence, emerging market penetration, and geographic strategy

1Regulated Markets

Genex Pharma's export portfolio includes products such as Protein, Nitroglycerin, Indomethacin, Temozolomide, and Digoxin, with significant market shares in various therapeutic categories. The company's adherence to WHO-GMP standards facilitates access to regulated markets, ensuring compliance with international quality and safety standards.

2Emerging Markets

Genex Pharma's global presence extends to over 50 countries, indicating a strategic focus on emerging markets. The company's commitment to ethical operations and integrity supports its expansion into diverse regions, including Africa, Latin America, and Southeast Asia.

3Geographic Strategy

Genex Pharma's export activities are concentrated in specific therapeutic categories, with the top five products accounting for 88% of the total export value. This concentration suggests a strategic focus on high-demand products, potentially mitigating risks associated with a diversified portfolio. The company's expansion into over 50 countries reflects a deliberate geographic diversification strategy.

Genex Pharma — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

Specific details regarding Genex Pharma's FDA facility registrations, approved ANDAs, DMF filings, and inspection history are not publicly disclosed. The company's adherence to WHO-GMP standards indicates a commitment to quality, which is essential for FDA approvals.

2WHO & EU GMP

Genex Pharma's manufacturing facilities are WHO-GMP compliant, ensuring adherence to international quality standards. While specific EU GMP certifications are not publicly disclosed, the company's commitment to quality suggests potential compliance with EU standards.

3CDSCO & Indian Regulatory

Genex Pharma operates under the regulations of the Central Drugs Standard Control Organisation (CDSCO) in India. Specific details regarding CDSCO manufacturing licenses, state drug controller approvals, and export No Objection Certificates (NOCs) are not publicly disclosed. The company's adherence to WHO-GMP standards indicates compliance with national regulatory requirements.

Genex Pharma — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

Genex Pharma operates in a competitive landscape with numerous pharmaceutical companies offering similar products. The company's focus on high-demand products such as Protein, Nitroglycerin, Indomethacin, Temozolomide, and Digoxin, with significant market shares, positions it competitively in the market. The company's adherence to WHO-GMP standards and ethical operations further enhances its competitive standing.

2Key Differentiators

Genex Pharma's key differentiators include its adherence to WHO-GMP standards, ensuring high-quality products, and its ethical operations and integrity across global activities. The company's focus on high-demand products with significant market shares demonstrates its strategic approach to product selection.

3Strategic Position

Genex Pharma's strategic direction focuses on manufacturing and exporting life-saving medicines across various therapeutic categories, including cardiovascular, oncology, hormonal-infertility, and anti-bacterials. The company's adherence to WHO-GMP standards and ethical operations supports its position in the generics and specialty pharmaceuticals sectors.

Buyer Due Diligence Brief — Evaluating Genex Pharma as a Supplier

Track record assessment, certifications to verify, and pre-order checks

1Supplier Assessment

Genex Pharma's adherence to WHO-GMP standards and ethical operations indicates a reliable track record in manufacturing and exporting pharmaceutical products. The company's export volume and consistency, with a presence in over 50 countries, reflect its reliability in global markets.

2Certifications to Verify

Importers should verify the following certifications when considering Genex Pharma:

WHO-GMP Certification: Ensures compliance with international quality standards.

EU GMP Certification: Indicates adherence to European manufacturing standards.

FDA Approval: Validates compliance with U.S. regulatory requirements.

ISO Certification: Demonstrates commitment to quality management systems.

Frequently Asked Questions — Genex Pharma

How many pharmaceutical products does Genex Pharma export from India?

Genex Pharma exports 8 pharmaceutical products across 6 therapeutic categories. The top exports are Protein ($108.7K), Nitroglycerin ($106.3K), Indomethacin ($51.5K), Temozolomide ($34.7K), Digoxin ($28.1K). Total export value is $374.1K.

What is Genex Pharma's total pharmaceutical export value?

Genex Pharma's total pharmaceutical export value is $374.1K, based on 108 verified shipments recorded in Indian Customs (DGFT) data.

What therapeutic categories does Genex Pharma cover?

Genex Pharma exports across 6 therapeutic categories. The largest are Cardiovascular (35.9%, 2 products), Nutritional Supplements (29.1%, 1 products), Analgesics & Antipyretics (13.8%, 1 products).

Get Full Genex Pharma Export Intelligence

Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify manufacturer licensing, GMP certification, and export registration with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. For current shipment-level data, contact TransData Nexus.

Genex Pharma

Genex Pharma — Export Portfolio & Destination Treemap

Who is Genex Pharma? — Company Overview & Market Position

What Does Genex Pharma Export? — Product Portfolio Analysis

Top Products by Export Value

Genex Pharma Therapeutic Categories — 6 Specializations